Skip to main content

Table 2 Univariate and multivariable linear regression results. Multivariable estimates are adjusted for all other predictors

From: Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study

Predictor

Unadjusted change in WMH volume at 1 year per unit change in predictor (95% CI)

Unadjusted p value

Adjusted change in WMH volume at 1 year per unit change in predictor (95% CI)

Adjusted p value

Baseline WMH volume, ml

0.88 (0.84 to 0.93)

<0.0001

0.73 (0.65 to 0.80)

<0.0001

Age

0.91 (0.64 to 1.17)

<0.0001

−0.02 (−0.14 to 0.10)

0.75

MAP

−0.11 (−0.33 to 0.11)

0.31

−0.10 (−0.19 to −0.02)

0.013

PP

0.19 (0.035 to 0.35)

0.017

0.03 (−0.03 to 0.10)

0.34

Hypertension

4.89 (−2.77 to 12.54)

0.21

−1.40 (−4.06 to 1.26)

0.30

Fazekas score

11.54 (10.43 to 12.65)

<0.0001

2.93 (1.76 to 4.10)

<0.0001

Stroke subtype

0.88 (−5.83 to 7.58)

0.80

−0.85 (−3.05 to 1.34)

0.44

Smoking status

−2.30 (−9.16 to 4.56)

0.51

0.17 (−2.24 to 2.57)

0.89

Diabetes

10.36 (−0.19 to 20.90)

0.054

−1.98 (−5.51 to 1.54)

0.27

Hyperlipidaemia

−0.51 (−7.36 to 6.34)

0.88

−1.10 (−3.40 to 1.19)

0.34

  1. Abbreviations: MAP Mean arterial pressure, PP Pulse pressure, WMH White matter hyperintensity